Longevità (Lifespan – Italian edition)
Camillo Ricordi’s introduction to the Italian edition of David Sinclair’s Lifespan, presenting ageing as a potentially reversible disease and exploring the role of epigenetics, novel anti-ageing molecules and the ethical imperative of extending healthy lifespan.
Read More
Eculizumab treatment in patients with COVID-19: preliminary results from real-life ASL Napoli 2 Nord experience
Real-life case series of four severe ICU COVID-19 patients treated with eculizumab: all achieved clinical recovery, with marked CRP reduction and a mean disease duration of about 13 days, supporting the potential role of anti-complement C5 therapy in severe cases.
Read More
Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19
Preliminary (March 2020) review examining in vitro studies, clinical trials, expert reports and COVID-19 prevalence in malaria and non-malaria countries to explore the hypothesis that chloroquine and hydroxychloroquine might be effective in treating COVID-19.
Read More
COVID-19: L’inizio di una nuova era
A scientific and educational volume exploring the COVID-19 pandemic across all dimensions: clinical aspects, diagnosis, treatments, social impact, healthcare, risk factors and institutional responses, enriched with expert contributions.
Read More
Editorial – Vitamin D status
Editorial highlighting vitamin D status as an important modulator of innate immunity and natural defense against acute viral respiratory infections, with potential clinical and preventive implications.
Read More
Manuale di Medicina Ambulatoriale – New Edition
New edition of the Manuale di Medicina Ambulatoriale, updated for the COVID-19 pandemic and expanded with sections on cancer screening, chronic conditions and regulatory and clinical tools to support physicians working in outpatient settings.
Read More
Point-of-Care Lung Ultrasound Findings in COVID-19 Pneumonia
Case report on the use of Point-of-Care lung ultrasound in a COVID-19 patient, highlighting its advantages during the pandemic: rapid assessment, reduced exposure, repeatability and suitability for low-resource settings.
Read More
Eculizumab treatment in patients with COVID-19
Case series describing four severe ICU COVID-19 patients treated with eculizumab at ASL Napoli 2 Nord: all patients recovered, with marked CRP reduction and a mean disease duration of about 13 days, suggesting a potential role for anti-complement C5 therapy as a therapeutic option.
Read More
COVID-19 (Novel Coronavirus 2019) – Recent Trends
Mini-review summarizing the most recent findings on COVID-19: transmission, genomic features, potential ACE2 receptor use, N protein characteristics, similarities to SARS-CoV and differences from MERS-CoV.
Read More
Novel Coronavirus 2019-nCoV
Comparative study analyzing prevalence, transmission and fatality rates of 2019-nCoV versus SARS-CoV and MERS-CoV, highlighting biological, clinical and epidemiological features and the need for global preventive measures.
Read More